Evidence map›Paper›PMID 37323624›Full record

ReviewExploration (Beijing, China)2023

Microneedle system for tissue engineering and regenerative medicine.

Yixin Zhang, Yanteng Xu, Huimin Kong, Jiabin Zhang, Hon Fai Chan, Jiasi Wang, Dan Shao, Yu Tao, Mingqiang Li

Open access · goldAbstract readReview
In one paragraph

Review in Exploration (Beijing, China), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
19.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 172 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Spatiotemporal controlled release of YCM/CuJournal of nanobiotechnology · 2026
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Rethinking asthma therapy, part 2: transdermal strategies for adjunct asthma and allergy treatments.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2026
    Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yixin ZhangLaboratory of Biomaterials and Translational Medicine Center for Nanomedicine The Third Affiliated Hospital Sun Yat-sen University Guangzhou China.
Yanteng XuLaboratory of Biomaterials and Translational Medicine Center for Nanomedicine The Third Affiliated Hospital Sun Yat-sen University Guangzhou China.
Huimin KongLaboratory of Biomaterials and Translational Medicine Center for Nanomedicine The Third Affiliated Hospital Sun Yat-sen University Guangzhou China.
Jiabin ZhangLaboratory of Biomaterials and Translational Medicine Center for Nanomedicine The Third Affiliated Hospital Sun Yat-sen University Guangzhou China.
Hon Fai ChanInstitute for Tissue Engineering and Regenerative Medicine School of Biomedical Science The Chinese University of Hong Kong Hong Kong China.
Jiasi WangSchool of Biomedical Engineering Sun Yat-sen University Shenzhen China.
Dan ShaoInstitutes of Life Sciences School of Medicine South China University of Technology Guangzhou China.
Yu TaoLaboratory of Biomaterials and Translational Medicine Center for Nanomedicine The Third Affiliated Hospital Sun Yat-sen University Guangzhou China.
Mingqiang LiLaboratory of Biomaterials and Translational Medicine Center for Nanomedicine The Third Affiliated Hospital Sun Yat-sen University Guangzhou China.
Sun Yat-sen University · CNChinese University of Hong Kong · HKSouth China University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global increasing demand for high life quality and length facilitates the development of tissue engineering and regenerative medicine, which apply multidisciplinary theories and techniques to achieve the structural reconstruction and functional recovery of disordered or damaged tissues and organs. However, the clinical performances of adopted drugs, materials, and powerful cells in the laboratory are inescapably limited by the currently available technologies. To tackle the problems, versatile microneedles are developed as the new platform for local delivery of diverse cargos with minimal invasion. The efficient delivery, as well as painless and convenient procedure endow microneedles with good patient compliance in clinic. In this review, we first categorize different microneedle systems and delivery models, and then summarize their applications in tissue engineering and regenerative medicine mainly involving maintenance and rehabilitation of damaged tissues and organs. In the end, we discuss the advantages, challenges, and prospects of microneedles in depth for future clinical translations.

Indexed as

microneedleregenerative medicinetissue engineering

Identifiers

PMID37323624
PMCPMC10190997
OpenAlexW4317661991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.